Comparison between ixazomib+cyclophosphamide+dexamethasone regimen and ixazomib+dexamethasone regimen for elderly and frail patients having newly diagnosed multiple myeloma

AIMS: The purpose of this prospective, randomized study was to investigate the effectiveness and safety of the ixazomib+cyclophosphamide+dexamethasone (ICd) and ixazomib+dexamethasone (Id) regimens in newly diagnosed multiple myeloma (NDMM) who were elderly and frail and to compare the two regimens....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shutan, Zhang, Duanzhong, Yang, Lihua, Huang, Chunlan, Niu, Ting, Gong, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067049/
https://www.ncbi.nlm.nih.gov/pubmed/36377601
http://dx.doi.org/10.1002/cam4.5422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067049/
https://www.ncbi.nlm.nih.gov/pubmed/36377601
http://dx.doi.org/10.1002/cam4.5422

Ejemplares similares